Filing Details

Accession Number:
0001289340-11-000053
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-19 13:16:47
Reporting Period:
2011-09-15
Filing Date:
2011-09-19
Accepted Time:
2011-09-19 13:16:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1289340 Stereotaxis Inc. STXS Electromedical & Electrotherapeutic Apparatus (3845) 943120386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267959 A Fred Middleton 400 South El Camino Real
Suite 1200
San Mateo CA 94402-1708
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-15 4,850 $1.38 319,755 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,581,607 Indirect Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock 30,609 Indirect Sanderling VI Beteiligungs GmbH & Co. KG
Common Stock 36,470 Indirect Sanderling VI Limited Partnership
Common Stock 16,116 Indirect Sanderling Ventures Management VI
Common Stock 781,351 Indirect Sanderling Venture Partners II, L.P.
Common Stock 15,000 Indirect Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan
Common Stock 532,758 Indirect Sanderling IV Biomedical Co-Investment Fund, L.P.
Common Stock 110,971 Indirect Sanderling V Beteiligungs GmbH & Co. KG
Common Stock 397,164 Indirect Sanderling V Biomedical Co-Investment Fund, L.P.
Common Stock 119,566 Indirect Sanderling V Limited Partnership
Common Stock 677,906 Indirect Sanderling Venture Partners V Co-Investment Fund, L.P.
Common Stock 224,515 Indirect Sanderling Venture Partners iV Co-Investment Fund
Common Stock 828 Indirect Sanderling Ventures Management V
Common Stock 797 Indirect Middleton McNeil Retirement Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.37 to $1.38, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc,. any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.